Who
Harith Rajagopalan
Chief Executive Officer
Company insider
Files Form 4 as: Chief Executive Officer, Fractyl Health.
In numbers
- Trades disclosed
- 19
- Buys
- 2
- Sells
- 3
- Bought
- $57K
- Sold
- $445K
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 6 Feb 2024
- Last trade
- 10 Jun 2026
- Last filed
- 11 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 10 Jun 2026filed 11 Jun 2026 | GUTS Fractyl HealthMedical Devices | SEC FORM 4 Bought | $18K25,000 at $0.7301 | filing |
| 10 Jun 2026filed 11 Jun 2026 | GUTS Fractyl HealthMedical Devices | SEC FORM 4 Bought | $18K25,000 at $0.73 | filing |
| 15 Dec 2025filed 17 Dec 2025 | GUTS Fractyl Healthoption or derivative · Medical Devices | SEC FORM 4 Code A | —2,486,302 at $0.00 | filing |
| 4 Dec 2025filed 8 Dec 2025 | GUTS Fractyl HealthMedical Devices | SEC FORM 4 Bought | $20K10,416 at $1.92 | filing |
| 27 Feb 2025filed 3 Mar 2025 | GUTS Fractyl Healthoption or derivative · Medical Devices | SEC FORM 4 Code A | —571,491 at $0.00 | filing |
| 27 Feb 2025filed 3 Mar 2025 | GUTS Fractyl Healthoption or derivative · Medical Devices | SEC FORM 4 Code A | —261,540 at $0.00 | filing |
| 31 Jan 2025filed 3 Feb 2025 | GUTS Fractyl Healthoption or derivative · Medical Devices | SEC FORM 4 Code M | —90,972 at $0.00 | filing |
| 31 Jan 2025filed 3 Feb 2025 | GUTS Fractyl HealthMedical Devices | SEC FORM 4 Code M | $155K90,972 at $1.70 | filing |
| 31 Jan 2025filed 3 Feb 2025 | GUTS Fractyl HealthMedical Devices | SEC FORM 4 Sold | $166K90,972 at $1.82 | filing |
| 30 Jan 2025filed 3 Feb 2025 | GUTS Fractyl Healthoption or derivative · Medical Devices | SEC FORM 4 Code M | —20,948 at $0.00 | filing |
| 30 Jan 2025filed 3 Feb 2025 | GUTS Fractyl HealthMedical Devices | SEC FORM 4 Code M | $36K20,948 at $1.70 | filing |
| 30 Jan 2025filed 3 Feb 2025 | GUTS Fractyl HealthMedical Devices | SEC FORM 4 Sold | $41K20,948 at $1.95 | filing |
| 11 Nov 2024filed 13 Nov 2024 | GUTS Fractyl HealthMedical Devices | SEC FORM 4 Sold | $238K96,517 at $2.47 | filing |
| 10 Nov 2024filed 13 Nov 2024 | GUTS Fractyl Healthoption or derivative · Medical Devices | SEC FORM 4 Code M | —216,924 at $0.00 | filing |
| 10 Nov 2024filed 13 Nov 2024 | GUTS Fractyl HealthMedical Devices | SEC FORM 4 Code M | —216,924 at $0.00 | filing |
| 6 Feb 2024filed 8 Feb 2024 | GUTS Fractyl Healthoption or derivative · Medical Devices | SEC FORM 4 Code C | —14,000 | filing |
| 6 Feb 2024filed 8 Feb 2024 | GUTS Fractyl Healthoption or derivative · Medical Devices | SEC FORM 4 Code C | —6,000 | filing |
| 6 Feb 2024filed 8 Feb 2024 | GUTS Fractyl HealthMedical Devices | SEC FORM 4 Code C | —6,523 | filing |
| 6 Feb 2024filed 8 Feb 2024 | GUTS Fractyl HealthMedical Devices | SEC FORM 4 Code C | —2,795 | filing |
News
Fractyl Health Sharpens Focus on Revita Following Positive Pivotal Results, Advancing Toward Planned FDA De Novo Submission in Post-GLP-1 Weight MaintenanceGUTS · manilatimes.net · 22 Oct 2026Fractyl Health Stock Plunges 48% Despite Positive Revita Weight-Maintenance Trial ResultsGUTS · rttnews.com · 16 Oct 2026Analyzing Zealand Pharma A/S (OTCMKTS:ZLDPF) & Fractyl Health (NASDAQ:GUTS)GUTS · themarketsdaily.com · 14 Oct 2026
0 headlines in the last 90 days name Harith Rajagopalan; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.